Dysregulated mTOR signaling is tightly associated with the development of several hyperproliferative skin disorders, including skin cancer, and inflammatory skin diseases (Buerger et al., 2013; Mossmann et al., 2018; Varshney and Saini, 2018; Deng et al., 2021). This evidence concerns the gene MTOR and skin cancer.